Some people are indeed born without a uterus. The condition responsible in the vast majority of cases is called Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, a congenital difference in which the uterus and the upper portion of the vagina fail to develop despite an otherwise typical female body. Estimated to affect roughly one in every 4,000 to 10,000 females at birth, MRKH is more common than many people realize, yet most who have it don’t learn about it until their mid-teens, when menstruation never arrives.
What MRKH Syndrome Actually Is
MRKH syndrome involves the absence, or severe underdevelopment, of the uterus and the upper two-thirds of the vagina in someone who has a normal female chromosome pattern (46,XX) and normal external genitalia.1Acta Medica International. Mayer–Rokitansky–Küster–Hauser Syndrome: A Rare Cause of Primary Amenorrhea The ovaries are present and functional, which means puberty unfolds on schedule: breast development, body hair, growth spurts, and all the hormonal changes that come with adolescence proceed as expected. What doesn’t happen is a period. Because there is no uterus to shed a lining, menstruation simply never begins.
This is typically the moment MRKH comes to light. A teenager or her parents become concerned about the absence of periods, and a medical workup eventually reveals the underlying anatomy. Hormone levels usually come back normal, and secondary sexual characteristics look entirely typical, which can make the absence of menstruation puzzling at first.2Journal of Nepal Paediatric Society. Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome Presenting with Primary Amenorrhea in an Adolescent Girl: Diagnostic and Clinical Insights It’s worth stressing that people with MRKH look and feel female in every outward respect. The condition is invisible until someone looks for it.
Two Types of MRKH
Clinicians classify MRKH into two broad forms. Type I, sometimes called the isolated form, involves only the reproductive tract: the uterus and upper vagina are absent, but no other organ systems are affected. Type II is more complex. In addition to the reproductive differences, people with Type II may have abnormalities in the kidneys, the spine, and sometimes the heart or hearing.3ESPE Abstracts. MRKH Type 2 with Menstruation: Unraveling an Unusual Case Type II is actually the more common presentation.4PubMed Central. Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome
When Type II includes the combination of absent uterus, kidney problems, and cervical spine differences, doctors sometimes use the term MURCS association (short for Müllerian duct aplasia, renal agenesis/ectopia, and cervicothoracic somite dysplasia). In one study of 52 patients with the atypical form, congenital spinal abnormalities were found in about a quarter, and the full MURCS pattern was present in roughly one in five of those patients.5PubMed. Spinal abnormalities and the atypical form of the Mayer-Rokitansky-Küster-Hauser syndrome The takeaway for anyone newly diagnosed is that additional screening, particularly for kidney and spine differences, is a routine and important part of the initial evaluation.
Kidney and Other Associated Conditions
Kidney anomalies are the most frequently seen extragenital feature. About 30 to 40 percent of all MRKH cases involve some form of upper urinary tract difference, which can range from having a single kidney, to a kidney that sits in an unusual position, to duplication of parts of the collecting system.6PubMed. Renal abnormalities in Mayer-Rokitanski-Küster-Hauser syndrome Many of these kidney differences cause no symptoms at all and are only discovered during the imaging done after the MRKH diagnosis. Still, knowing about them matters for long-term care, because a single functioning kidney changes how aggressively you’d want to protect it from injury or infection over a lifetime.
Cardiac and auditory defects are less common but do occur, mainly in Type II. These are generally identified through the same comprehensive workup that looks for kidney and spine issues. The practical message is that MRKH is sometimes more than a reproductive condition, and early screening helps catch associated differences before they cause problems.
Why MRKH Happens
During early fetal development, the reproductive tract forms from paired tubes called the Müllerian ducts. In typical female development, these ducts fuse together to become the uterus, cervix, fallopian tubes, and the upper vagina. In MRKH syndrome, something goes wrong in this process: the ducts either fail to form at all or begin developing but don’t complete the job. The ovaries develop from a different embryological origin, which is why they’re usually unaffected.
The exact cause remains incompletely understood, and that’s one of the more frustrating aspects of MRKH for patients and researchers alike. A systematic review of genetic studies has identified several chromosomal regions and genes that show up repeatedly in MRKH cases, including regions on chromosomes 1, 7, 16, 17, and 22, with genes like WNT4, TBX6, LHX1, and HNF1B among the candidates.7PubMed Central. Identification of Genetic Causes in Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome: A Systematic Review of the Literature In a subset of patients who also show signs of excess androgen activity, mutations in the WNT4 gene have been identified as a direct cause.8PubMed Central. Clinical and genetic aspects of Mayer-Rokitansky-Küster-Hauser syndrome Animal research supports this direction: when researchers knocked out both the Wnt4 and Wnt5a genes in mouse reproductive tissue, some of the female mice developed partial absence of their Müllerian duct structures while retaining normal ovaries and oviducts, mirroring what we see in humans.9PubMed Central. Targeted ablation of Wnt4 and Wnt5a in Müllerian duct mesenchyme impedes endometrial gland development and causes partial Müllerian agenesis
But no single gene explains most cases. The pattern of inheritance, when there is any family clustering, doesn’t follow a simple one-gene model. Environmental factors during pregnancy have been investigated, too, though nothing definitive has emerged. Most cases appear sporadic, meaning they occur without a clear family history. Parents should know there is nothing they did or failed to do during pregnancy that caused this.
How MRKH Is Diagnosed
The diagnostic process typically begins when a teenager with otherwise normal puberty hasn’t gotten her period by age 15 or 16. After a physical exam confirms normal external anatomy and rules out an imperforate hymen or other simple obstruction, imaging takes center stage. Transabdominal ultrasound is often the first step, because it’s noninvasive and widely available.10Journal of Diagnostic Medical Sonography. Sonographic Detection of Mayer-Rokitansky-Küster-Hauser Syndrome When ultrasound suggests an absent uterus, pelvic MRI typically follows to confirm the diagnosis in detail and to evaluate for associated kidney or spinal differences.11International Journal of Biomedicine. The Role of MRI in Diagnosing Mayer-Rokitansky-Kuster-Hauser Syndrome: A Case Study
One critical piece of the workup is confirming a 46,XX chromosome pattern, because another condition, complete androgen insensitivity syndrome (CAIS), can look superficially similar: a person who appears female externally but lacks a uterus. The key difference is that someone with CAIS has a 46,XY karyotype and testes (usually undescended) rather than ovaries. Chromosome testing distinguishes the two conditions cleanly and changes management significantly.
Ovaries and Hormones Work Normally
A common worry after an MRKH diagnosis is whether the hormonal system still functions. In the vast majority of cases, it does. A study that assessed hormone levels in 56 MRKH patients found that their pituitary and steroid hormone profiles were generally comparable to those of controls, and the patients could be grouped into recognizable hormonal phases consistent with a normal ovarian cycle.12PubMed. Assessment of pituitary and steroid hormones and members of the TGF-beta superfamily for ovarian function in patients with congenital uterus and vaginal aplasia (MRKH syndrome) In plain terms, the ovaries release eggs and produce estrogen and progesterone on a monthly rhythm, just as they would in anyone else. A small fraction of patients, around five percent in that study, had streak ovaries or were missing one ovary, but this is the exception.
What this means practically is that someone with MRKH goes through the same hormonal fluctuations as anyone with functioning ovaries. They may experience cyclic cramping, breast tenderness, or mood changes on a monthly basis, even without menstruation, because the hormones driving those symptoms are still circulating. It also means that genetic motherhood is possible, since the ovaries produce viable eggs, though carrying a pregnancy requires a uterus that someone with MRKH does not have.
Creating a Functional Vagina
Because MRKH typically involves absence of the upper vagina, one of the first practical concerns for many patients is whether vaginal intercourse will be possible. The answer is yes, and the preferred first-line approach is nonsurgical.
The technique most widely used is vaginal dilation, sometimes called Frank’s method. It involves using a set of smooth dilators of gradually increasing size, applied with gentle pressure to the vaginal dimple (the small remnant of vaginal tissue that is usually present). Over weeks to months, the tissue stretches and a functional vaginal canal forms. A prospective study of 45 MRKH patients who underwent dilation therapy reported a functional success rate of 89 percent, with a median time to success of a little over four months.13PubMed. Sexual functional outcomes of vaginal dilation therapy for MRKH syndrome: a prospective study The process requires motivation and consistency, and research suggests that patients over 18 who choose to begin treatment, particularly those in a relationship or actively wanting to become sexually active, tend to have the highest success rates.14PubMed Central. Conservative Management of Vaginal Hypoplasia
When dilation doesn’t succeed or isn’t appropriate, surgical creation of a neovagina is the backup. Several surgical techniques exist, including the modified McIndoe procedure (which uses a skin graft to line a newly created canal) and the Davydov procedure (which uses a section of the peritoneal lining). A comparative study of the two approaches in MRKH patients found both produced satisfactory vaginal dimensions at six months, though the McIndoe group had somewhat more postoperative complications.15PubMed Central. Comparison of modified McIndoe and Davydov vaginoplasty in patients with MRKH syndrome in terms of anatomical results, sexual performance and satisfaction A separate head-to-head comparison of dilation versus surgical neovaginoplasty found no significant differences in final vaginal length or sexual function scores between the two approaches, reinforcing that dilation remains a valid first choice.16PubMed. Treatment for vaginal agenesis: A prospective and comparative study between vaginal dilation and surgical neovaginoplasty
Paths to Parenthood
Because MRKH involves absent or rudimentary uterus while the ovaries function normally, the eggs are there but there’s no organ in which to carry a pregnancy. This creates a specific fertility scenario that has two main solutions available today: gestational surrogacy and uterine transplantation.
Gestational surrogacy combined with IVF is the more established route. The MRKH patient undergoes ovarian stimulation and egg retrieval, the eggs are fertilized in the lab, and the resulting embryo is transferred to a surrogate who carries the pregnancy. A systematic review found that among 125 MRKH patients who pursued this path across multiple studies, 369 IVF cycles resulted in the birth of 71 babies.17Reproductive BioMedicine Online. Reproductive outcome of patients with Mayer–Rokitansky–Küster–Hauser syndrome treated by IVF and gestational surrogacy: a systematic review That ratio reflects the general challenges of IVF rather than anything specific to MRKH, since the ovarian response in these patients is typically normal.
Uterine transplantation is a newer and more dramatic option. Beginning in the early 2010s, surgeons began transplanting donated uteruses into women with MRKH, allowing them to carry their own pregnancies. By mid-2017, 42 women worldwide had received transplanted uteruses, and 11 babies had been born as a result.18PubMed Central. Uterus Transplantation as a Therapy Method in Mayer-Rokitansky-Küster-Hauser Syndrome Those numbers have continued to grow since. The transplanted uterus is not permanent; it is removed after the patient has completed her desired pregnancies, so she doesn’t need lifelong immunosuppression. The procedure remains highly specialized, available at only a handful of centers, and is not covered by most insurance plans. But it represents a proof of concept that was unimaginable a generation ago: a person born without a uterus carrying and delivering her own child.
The Emotional Weight of the Diagnosis
Learning that you were born without a uterus, often as a teenager, carries a psychological impact that the clinical literature consistently confirms. Research on psychological distress in women with MRKH has found significantly elevated scores on measures of phobic anxiety and interpersonal alienation compared to the general population, along with trends toward higher depression and anxiety. The study’s authors concluded that MRKH has a lasting negative effect on psychological well-being and self-esteem.19PubMed. Psychological distress in women with uterovaginal agenesis (Mayer-Rokitansky-Kuster-Hauser Syndrome, MRKH)
Part of the distress stems from the condition’s intersection with identity. For many young women, the ability to menstruate and someday carry a pregnancy feels central to their sense of womanhood, and learning that these experiences won’t happen in the usual way can feel like a fundamental loss. The feeling of being “different” often precedes the diagnosis, since the absence of periods during a developmental stage when peers are all talking about theirs can be deeply isolating.
The good news is that psychological support makes a measurable difference. A prospective study of 30 MRKH patients who received structured psychological intervention after vaginoplasty found that both depression and anxiety scores dropped significantly, and the benefit was especially strong when the intervention began within the first year after surgery.20PubMed Central. Psychological intervention in women with Mayer-Rokitansky-Küster-Hauser syndrome after artificial vaginoplasty: a prospective study Unfortunately, mental health support is not yet a standard part of MRKH care at every center, which is a gap that advocacy groups and clinicians have been working to close.
Telling Other People
One of the less-discussed challenges of living with MRKH is deciding who to tell, and when. A qualitative study exploring how young women with MRKH share their diagnosis with peers found that the decision is deeply fraught. The main motivators for disclosing included strong trust in a relationship, the need to unburden themselves of the emotional weight of the diagnosis, and a sense of responsibility toward a romantic partner with whom they envisioned a future. The most common barrier was fear of being rejected or seen as a “freak.”21PubMed. The Lived Experience of MRKH: Sharing Health Information with Peers
Perhaps the most striking finding from that study was that almost all participants wished they had received guidance from a healthcare provider on how to approach these conversations, but very few had actually gotten it. This gap between what patients need and what the medical system offers highlights how MRKH care should extend well beyond imaging and surgery. Practical coaching on how to talk about the condition with friends, partners, and family is a form of care that many patients would value as much as the physical treatments.
Online communities and patient organizations have become lifelines for many women with MRKH, offering peer connection and the reassurance that comes from meeting others who share the same experience. Groups like the MRKH Organization and Beautiful You MRKH Foundation provide both informational resources and moderated forums. For a condition that can feel profoundly isolating, the knowledge that thousands of other women have navigated the same questions about identity, relationships, and parenthood can be one of the most powerful treatments available.
Common Misconceptions
A few myths deserve clearing up. One is that people with MRKH are intersex. While MRKH involves a difference in reproductive anatomy, the chromosomal sex (46,XX), the external genitalia, the hormonal profile, and the gender identity are all typically female. MRKH is classified as a Müllerian duct anomaly, not a disorder of sex development, though some academic frameworks group it under the broader umbrella of differences in sexual development, which can create confusion.
Another misconception is that MRKH means you “can’t have sex.” As outlined above, vaginal dilation or surgery allows the vast majority of patients to have comfortable vaginal intercourse. A third myth is that people with MRKH can never have biological children. They can: the ovaries produce eggs, and those eggs can be fertilized through IVF and carried by a surrogate or, increasingly, in a transplanted uterus. The route to parenthood is different, but genetic motherhood is achievable.
Finally, there’s a persistent belief that MRKH is caused by something the mother did during pregnancy. No evidence supports this. The genetic and developmental roots of MRKH are complex and still being mapped, but the research points toward inherent variations in early embryonic signaling, not anything related to maternal behavior, diet, or exposure.
Hearing and Cardiac Screening in Type II
While kidney and spinal differences get the most attention in MRKH Type II, auditory and cardiac anomalies also occur. Hearing loss, when present, tends to involve the middle ear or inner ear structures and may be subtle enough that it goes unnoticed without formal audiometry. Cardiac differences range from minor structural variants, such as a bicuspid aortic valve, to more clinically significant congenital heart defects. Neither is common enough to expect in any individual patient, but both are common enough in the Type II population to justify routine screening at the time of diagnosis.4PubMed Central. Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome An echocardiogram and an audiology evaluation are quick, low-risk, and can catch problems that are far easier to manage when identified early rather than discovered incidentally years later.